Close Menu
Alpha Leaders
  • Home
  • News
  • Leadership
  • Entrepreneurs
  • Business
  • Living
  • Innovation
  • More
    • Money & Finance
    • Web Stories
    • Global
    • Press Release
What's On
Latest AI Behaves More Like Humans By Rudely Interrupting You During Conversational Chats And We Might Relish It

Latest AI Behaves More Like Humans By Rudely Interrupting You During Conversational Chats And We Might Relish It

21 May 2026
Microsoft lost its way in the AI race. Can Copilot get it back on course?

Microsoft lost its way in the AI race. Can Copilot get it back on course?

21 May 2026
Kordata Launches To Power Next-Gen Clinical Trials

Kordata Launches To Power Next-Gen Clinical Trials

21 May 2026
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Alpha Leaders
newsletter
  • Home
  • News
  • Leadership
  • Entrepreneurs
  • Business
  • Living
  • Innovation
  • More
    • Money & Finance
    • Web Stories
    • Global
    • Press Release
Alpha Leaders
Home » ‘Feel-Good Neurotransmitter’ Dopamine May Improve Memory Of Alzheimer’s Patients, Study Suggests
Innovation

‘Feel-Good Neurotransmitter’ Dopamine May Improve Memory Of Alzheimer’s Patients, Study Suggests

Press RoomBy Press Room6 August 20244 Mins Read
Facebook Twitter Copy Link Pinterest LinkedIn Tumblr Email WhatsApp
‘Feel-Good Neurotransmitter’ Dopamine May Improve Memory Of Alzheimer’s Patients, Study Suggests

Topline

Researchers have found that increasing dopamine production in mice with Alzheimer’s disease improves their memory, a process they’re hopeful can be replicated in humans, though more testing for a better human alternative must be done.

Key Facts

A research team from Japan’s RIKEN Center for Brain Science tested the new treatment method, boosting the production of dopamine in the brains of mice with Alzheimer’s in the hopes of increasing levels of an enzyme called neprilysin.

Prior research has shown neprilysin can reduce the production of protein pieces called beta-amyloid, which causes the formation of plaque around brain neurons—one of the earliest indicators of Alzheimer’s disease—and the research team had previously found the neurotransmitter dopamine increases levels of neprilysin.

The scientists were able to continuously activate the neurons in the mice’s brains that produce dopamine, and after eight weeks the mice had significantly fewer plaques in their brains, according to a new study published Tuesday in Science Signaling.

Next, levodopa—a Parkinson’s drug used as a dopamine replacement—was given to some of the mice because, although the drug has severe side effects, boosting dopamine production in humans with a medication is a more feasible treatment method than genetically manipulating growth like the researchers did with the mice.

The medication was given for three months and led to an increase in neprilysin and a subsequent decrease in beta-amyloid, and the mice that were given this treatment performed better on memory tests than the placebo group that wasn’t treated with the drug.

What Side Effects Does Levodopa Have?

The researchers believe levodopa—also known as L-DOPA—is a good starting point to begin research on human treatment of boosting dopamine production in Alzheimer’s patients, but it may not be the best option in the long run because it has “serious side effects” in some Parkinson’s patients. Some of the most common side effects include dizziness, nausea, confusion, hallucination, psychosis, low blood pressure, agitation and delusion, according to StatPearls research. Long-term use can lead to complications like irreversible motor function changes, which affects roughly 50% of patients who take the drug for five to 10 years. Because of these side effects, “our next step is to investigate how dopamine regulates neprilysin in the brain, which should yield a new preventive approach that can be initiated at the preclinical stage of Alzheimer’s disease,” Dr. Watamura Naoto, first author of the study and researcher with the RIKEN Center for Brain Science, said in a statement.

What Is Dopamine?

Dopamine—also known as the “feel-good neurotransmitter”—is a hormone and a type of neurotransmitter in the brain that’s used by the nervous system to send messages to the nerves, according to the Cleveland Clinic. It plays an important role in the brain’s reward system because it’s released by the brain when a person does something that’s pleasurable. This rush of dopamine causes a person to seek more of that feeling, which can lead to behaviors like drug and alcohol addiction and overeating, according to the Cleveland Clinic. Research has shown the hormone may play a big part in dementia because low dopamine levels may indicate early signs of Alzheimer’s disease and other forms of dementia.

Big Number

6.7 million. That’s how many Americans aged 65 years or older had Alzheimer’s in 2023, according to the Alzheimer’s Association. Around one in nine people aged 65 or older have Alzheimer’s.

Tangent

Erectile dysfunction drugs like Viagra may also be key Alzheimer’s treatments, according to a Neurology study published in February. The researchers found participants who were prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s than their counterparts who weren’t. The types of drugs used in the study are called phosphodiesterase type-5 inhibitors, and the researchers believe PDE5Is may reduce Alzheimer’s risk because some forms of the drugs can improve brain health by increasing blood flow to the brain, and reducing the amount of energy neurons consumed in the brain.

Further Reading

Erectile Dysfunction Drugs Like Viagra May Reduce Alzheimer’s Risk, Study Finds (Forbes)

Alzheimer
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link

Related Articles

Latest AI Behaves More Like Humans By Rudely Interrupting You During Conversational Chats And We Might Relish It

Latest AI Behaves More Like Humans By Rudely Interrupting You During Conversational Chats And We Might Relish It

21 May 2026
Kordata Launches To Power Next-Gen Clinical Trials

Kordata Launches To Power Next-Gen Clinical Trials

21 May 2026
‘Escape From Tarkov’ Icebreaker Delayed As Current Event Extended

‘Escape From Tarkov’ Icebreaker Delayed As Current Event Extended

21 May 2026
‘The Boys’ Series Finale Is A Crushing Disappointment

‘The Boys’ Series Finale Is A Crushing Disappointment

21 May 2026
Google I/O 2026 Turned Gemini Into An Agent Platform

Google I/O 2026 Turned Gemini Into An Agent Platform

21 May 2026
Meta Expands Its Creator Ecosystem With Instagram’s New Instants App

Meta Expands Its Creator Ecosystem With Instagram’s New Instants App

21 May 2026
Don't Miss
Unwrap Christmas Sustainably: How To Handle Gifts You Don’t Want

Unwrap Christmas Sustainably: How To Handle Gifts You Don’t Want

By Press Room27 December 2024

Every year, millions of people unwrap Christmas gifts that they do not love, need, or…

Exclusive: DeFi platform Azura launches after raising .9 million from Initialized

Exclusive: DeFi platform Azura launches after raising $6.9 million from Initialized

22 October 2024
Walmart dominated, while Target spiraled: the winners and losers of retail in 2024

Walmart dominated, while Target spiraled: the winners and losers of retail in 2024

30 December 2024
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Latest Articles
‘Escape From Tarkov’ Icebreaker Delayed As Current Event Extended

‘Escape From Tarkov’ Icebreaker Delayed As Current Event Extended

21 May 20262 Views
‘The Boys’ Series Finale Is A Crushing Disappointment

‘The Boys’ Series Finale Is A Crushing Disappointment

21 May 20261 Views
Harvard admits it was too easy to get A grades, vows crackdown

Harvard admits it was too easy to get A grades, vows crackdown

21 May 20262 Views
Google I/O 2026 Turned Gemini Into An Agent Platform

Google I/O 2026 Turned Gemini Into An Agent Platform

21 May 20260 Views

Recent Posts

  • Latest AI Behaves More Like Humans By Rudely Interrupting You During Conversational Chats And We Might Relish It
  • Microsoft lost its way in the AI race. Can Copilot get it back on course?
  • Kordata Launches To Power Next-Gen Clinical Trials
  • Vance rebuffs Trump stock trading question, says Trump is so wealthy he doesn’t trade stocks himself
  • ‘Escape From Tarkov’ Icebreaker Delayed As Current Event Extended

Recent Comments

No comments to show.
About Us
About Us

Alpha Leaders is your one-stop website for the latest Entrepreneurs and Leaders news and updates, follow us now to get the news that matters to you.

Facebook X (Twitter) Pinterest YouTube WhatsApp
Our Picks
Latest AI Behaves More Like Humans By Rudely Interrupting You During Conversational Chats And We Might Relish It

Latest AI Behaves More Like Humans By Rudely Interrupting You During Conversational Chats And We Might Relish It

21 May 2026
Microsoft lost its way in the AI race. Can Copilot get it back on course?

Microsoft lost its way in the AI race. Can Copilot get it back on course?

21 May 2026
Kordata Launches To Power Next-Gen Clinical Trials

Kordata Launches To Power Next-Gen Clinical Trials

21 May 2026
Most Popular
Vance rebuffs Trump stock trading question, says Trump is so wealthy he doesn’t trade stocks himself

Vance rebuffs Trump stock trading question, says Trump is so wealthy he doesn’t trade stocks himself

21 May 20261 Views
‘Escape From Tarkov’ Icebreaker Delayed As Current Event Extended

‘Escape From Tarkov’ Icebreaker Delayed As Current Event Extended

21 May 20262 Views
‘The Boys’ Series Finale Is A Crushing Disappointment

‘The Boys’ Series Finale Is A Crushing Disappointment

21 May 20261 Views

Archives

  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • March 2022
  • January 2021
  • March 2020
  • January 2020

Categories

  • Blog
  • Business
  • Entrepreneurs
  • Global
  • Innovation
  • Leadership
  • Living
  • Money & Finance
  • News
  • Press Release
© 2026 Alpha Leaders. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.